Recce Pharmaceuticals Ltd

We're fighting antibiotic-resistant #superbugs with our innovative synthetic anti-infectives! 💊 🔬✨ #Innovation #AntibioticResistance #UTI #DFI

What defines Recce’s investment story? A unique mechanism targeting ATP production. Late-stage clinical progress. A growing role in addressing antimicrobial resistance. via @Edison_Inv_Res edisongroup.com/edison-tv/recc…

Nearly a century after penicillin ushered in the first antibiotic revolution, @ReccePharma $RCE is aiming to help deliver the next class of antibiotics to tackle drug-resistant superbugs. stockhead.com.au/health/no-more…

In diabetic foot infections, infection is more than a clinical event. It represents a moment where direction can shift. Earlier recognition and timely management may influence outcomes. As infection progresses, options can become more limited. #DiabeticFoot #DFI #InfectionAwareness #AMR #WoundCare #Healthcare

Stockhead TV host Tylah Tully sits down with @ReccePharma $RCE managing director and CEO James Graham as he outlines how the company’s synthetic anti-infective platform represents the first new class of antibiotics in over 40 years. stockhead.com.au/stockhead-tv/l…

$RCE Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight tinyurl.com/23by6rle @ReccePharma $RECEF #RCE #RECEF #ASX #ASXNews

Diabetic foot infections can be difficult to treat, particularly when reduced blood flow limits how effectively antibiotics reach the site of infection. This highlights the importance of approaches that can act directly at the site of infection. #DFI #AMR #Biotech #InfectiousDisease

Hospital-acquired infections are increasingly difficult to treat due to antimicrobial resistance. Understanding resistance patterns remains critical in managing serious infections in clinical settings. #AMR #HospitalInfections #Biotech #GlobalHealth

Biocurious: US military enlists Aussie biotechs in the germ warfare battle via @StockheadAU stockhead.com.au/health/biocuri…

@ReccePharma has strengthened its global intellectual property position by securing a key patent in Brazil. #ASX #health $RCE stockhead.com.au/health/recce-l…

#ASX Announcement - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q), is pleased to announce the Brazilian National Institute of Industrial Property (INPI) has formally granted a Family 4 patent for Recce’s Anti-Infectives, expiry 2041. Read the full ann here: recce.com.au/company-announ…

Missed our investor webinar? The full session is now available on our YouTube channel. Watch the recording here: youtu.be/yiks34nKzqk

Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) will host an investor webinar on 19 March at 10:30am AEDT. Updates will include the Phase 3 DFI trial in Indonesia, the U.S. Department of Defense burn wound program, and Recce’s broader anti-infective portfolio. Register here: us02web.zoom.us/webinar/regist…

$RCE Recce to host webinar on Phase 3 trial and anti-infective pipeline update tinyurl.com/26pqoq62 @ReccePharma $RECEF #RCE #RECEF #ASX #ASXNews

Diabetic Foot Infections are one of the leading causes of diabetes-related amputations worldwide. Early recognition and effective infection management remain critical in reducing the risk of severe complications. #DFI #DiabetesCare #AMR #GlobalHealth

In acute infections, bacterial growth can escalate quickly, increasing inflammatory burden and tissue damage. Understanding infection progression highlights the importance of early intervention. #InfectiousDisease #AMR #HealthcareInnovation

Acute infections present unique clinical challenges. Rapid progression and limited treatment windows make early intervention critical in serious bacterial infections. #AntimicrobialResistance #SeriousBacterialInfections #InfectiousDiseases #AMR #Healthcare

Antimicrobial resistance is one of the most significant global health threats of our time. @SBSNews highlights Australian research tackling #AMR, including Recce’s work developing a new class of synthetic anti-infectives designed to address resistant infections. Read the full article: sbs.com.au/news/article/a…

In a peer-reviewed study, multidrug-resistant infections were associated with significantly higher treatment failure and hospital readmission compared with non-resistant infections. These findings highlight the broader clinical burden associated with antimicrobial resistance. #AntimicrobialResistance #AMR #MultidrugResistance #Superbugs #HospitalInfections #InfectiousDiseases #ClinicalResearch

The rise of hospital-acquired infections reinforces the need for sustained focus on antimicrobial resistance and serious bacterial infections. #AntimicrobialResistance #HAI #InfectiousDiseases #HealthcareInnovation #AMR

$RCE Recce Pharmaceuticals signs second US Army CRADA - ICYMI tinyurl.com/2ytp2nmt @ReccePharma $RECEF #RCE #RECEF #ASX #ASXNews